Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |